Inhibitors for GlyT-1
    33.
    发明申请
    Inhibitors for GlyT-1 失效
    GlyT-1抑制剂

    公开(公告)号:US20080058331A1

    公开(公告)日:2008-03-06

    申请号:US11895097

    申请日:2007-08-23

    摘要: The present invention relates to compounds of formula I wherein R1, R2, R3, R4, and X are as defined herein or to pharmaceutically acceptable acid addition salts thereof, with the exception of 4-methoxy-N-[2-oxo-2-(phenylamino)ethyl]-N-phenyl-benzamide, 4-chloro-N-[2-[(4-methylphenyl)amino]-2-oxoethyl]-N-phenyl-benzamide, 4-chloro-N-[2-[5-chloro-2-methoxyphenyl)amino]-2-oxoethyl]-N-benzamide, 4-methyl-N-[2-oxo-2-[(2,4,6-trichlorophenyl)amino]ethyl]-N-benzamide, N-[2-[(4-methylphenyl)amino]-2-oxoethyl]-N-phenyl-benzamide, 4-methyl-N-[2-[(4-methylphenyl)amino]-2-oxoethyl]-N-phenyl-benzamide, 4-chloro-N-(2-oxo-2-[(2,4,6-trichlorophenyl)amino]ethyl]-N-benzamide and N-[2-[(2,4-dimethoxyphenyl)amino]-2-oxoethyl]-N-[(2-fluorophenyl)methyl]-benzeneacetamide. The compounds are useful in the treatment of neurological and neuropsychiatric disorders.

    摘要翻译: 本发明涉及式Ⅰ化合物,其中R 1,R 2,R 3,R 4, 和X如本文所定义,或其药学上可接受的酸加成盐,除了4-甲氧基-N- [2-氧代-2-(苯基氨基)乙基] -N-苯基 - 苯甲酰胺,4-氯-N- [2 - [(4-甲基苯基)氨基] -2-氧代乙基] -N-苯基 - 苯甲酰胺,4-氯-N- [2- [5-氯-2-甲氧基苯基)氨基] -2-氧代乙基] -N - 苯甲酰胺,4-甲基-N- [2-氧代-2 - [(2,4,6-三氯苯基)氨基]乙基] -N-苯甲酰胺,N- [2 - [(4-甲基苯基)氨基] -2 - 氧代乙基] -N-苯基 - 苯甲酰胺,4-甲基-N- [2 - [(4-甲基苯基)氨基] -2-氧代乙基] -N-苯基 - 苯甲酰胺,4-氯-N-(2-氧代 - 2 - [(2,4,6-三氯苯基)氨基]乙基] -N-苯甲酰胺和N- [2 - [(2,4-二甲氧基苯基)氨基] -2-氧代乙基] -N - [(2-氟苯基) 甲基] - 苯乙酰胺。这些化合物可用于治疗神经和神经精神障碍。

    Benzoyl-tetrahydropiperidine derivatives
    37.
    发明申请
    Benzoyl-tetrahydropiperidine derivatives 失效
    苯甲酰基 - 四氢哌啶衍生物

    公开(公告)号:US20060148797A1

    公开(公告)日:2006-07-06

    申请号:US11302403

    申请日:2005-12-13

    IPC分类号: A61K31/5377 C07D413/02

    CPC分类号: C07D211/70

    摘要: The present invention relates to compounds of formula I wherein R1, R2, and Ar; are as defined in the specification. The invention also provides pharmaceutically acceptable acid addition salts thereof and methods for the treatment of neurological and neuropsychiatric disorders, such as schizophrenia, cognitive impairment, and Alzheimer's disease.

    摘要翻译: 本发明涉及式I化合物,其中R 1,R 2,R 2和Ar; 如说明书中所定义。 本发明还提供其药学上可接受的酸加成盐以及用于治疗神经和神经精神疾病如精神分裂症,认知障碍和阿尔茨海默病的方法。

    Diaza-spiropiperidine derivatives
    40.
    发明申请
    Diaza-spiropiperidine derivatives 失效
    二氮杂 - 哌啶衍生物

    公开(公告)号:US20050154000A1

    公开(公告)日:2005-07-14

    申请号:US11028125

    申请日:2005-01-03

    CPC分类号: C07D471/10

    摘要: The present invention relates to compounds of formula wherein A—B, R1, R2, R3, R4, and n are as defined herein; and to pharmaceutically acceptable salts thereof. The compounds of formula I may be used in the treatment of neurological and neuropsychiatric disorders.

    摘要翻译: 本发明涉及下式的化合物,其中AB,R 1,R 2,R 3,R 4, ,和n如本文所定义; 和其药学上可接受的盐。 式I化合物可用于治疗神经和神经精神障碍。